S.E.E.D. Planning Group LLC boosted its stake in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 676.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,059 shares of the company's stock after acquiring an additional 16,604 shares during the quarter. S.E.E.D. Planning Group LLC's holdings in Colgate-Palmolive were worth $1,626,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently made changes to their positions in the company. State Street Corp lifted its holdings in Colgate-Palmolive by 97.4% during the 2nd quarter. State Street Corp now owns 94,195,992 shares of the company's stock valued at $8,635,889,000 after purchasing an additional 46,476,510 shares during the last quarter. Bank of New York Mellon Corp grew its stake in Colgate-Palmolive by 8.1% during the second quarter. Bank of New York Mellon Corp now owns 13,532,417 shares of the company's stock worth $1,240,652,000 after buying an additional 1,010,872 shares during the last quarter. Deutsche Bank AG increased its holdings in shares of Colgate-Palmolive by 33.9% during the fourth quarter. Deutsche Bank AG now owns 10,845,857 shares of the company's stock worth $857,040,000 after buying an additional 2,746,920 shares in the last quarter. First Eagle Investment Management LLC raised its stake in shares of Colgate-Palmolive by 1.1% in the second quarter. First Eagle Investment Management LLC now owns 8,205,699 shares of the company's stock valued at $752,298,000 after acquiring an additional 88,917 shares during the last quarter. Finally, Bank of America Corp DE boosted its holdings in shares of Colgate-Palmolive by 17.4% in the 1st quarter. Bank of America Corp DE now owns 6,637,597 shares of the company's stock worth $565,722,000 after acquiring an additional 986,063 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company's stock.
Colgate-Palmolive Trading Up 0.6%
NYSE CL traded up $0.51 during trading on Wednesday, reaching $87.76. 1,095,822 shares of the stock traded hands, compared to its average volume of 5,697,508. Colgate-Palmolive Company has a fifty-two week low of $74.54 and a fifty-two week high of $99.33. The company has a quick ratio of 0.67, a current ratio of 1.03 and a debt-to-equity ratio of 13.82. The firm has a market cap of $69.96 billion, a price-to-earnings ratio of 34.83, a price-to-earnings-growth ratio of 4.02 and a beta of 0.33. The stock's 50-day moving average price is $89.36 and its 200 day moving average price is $88.74.
Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings data on Friday, July 31st. The company reported $0.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.95 by $0.04. The business had revenue of $5.36 billion during the quarter, compared to analyst estimates of $5.36 billion. Colgate-Palmolive had a return on equity of 464.63% and a net margin of 9.68%.Colgate-Palmolive's quarterly revenue was up 4.9% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.92 EPS. Analysts predict that Colgate-Palmolive Company will post 3.87 EPS for the current year.
Colgate-Palmolive Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Tuesday, October 20th will be issued a $0.53 dividend. This represents a $2.12 annualized dividend and a yield of 2.4%. The ex-dividend date of this dividend is Tuesday, October 20th. Colgate-Palmolive's dividend payout ratio is currently 84.13%.
Analyst Upgrades and Downgrades
Several equities analysts have issued reports on CL shares. Jefferies Financial Group reiterated a "hold" rating on shares of Colgate-Palmolive in a research report on Monday, August 3rd. Morgan Stanley restated an "overweight" rating and issued a $104.00 price objective on shares of Colgate-Palmolive in a research report on Monday, August 3rd. UBS Group upped their target price on shares of Colgate-Palmolive from $106.00 to $109.00 and gave the stock a "buy" rating in a research report on Monday, August 3rd. Deutsche Bank Aktiengesellschaft reissued a "buy" rating and issued a $101.00 price target on shares of Colgate-Palmolive in a report on Monday, August 3rd. Finally, Sanford C. Bernstein reiterated a "market perform" rating on shares of Colgate-Palmolive in a research report on Thursday, August 13th. Twelve equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat.com, Colgate-Palmolive currently has a consensus rating of "Moderate Buy" and a consensus price target of $98.65.
Get Our Latest Stock Report on Colgate-Palmolive
Insider Activity
In related news, CEO Noel Wallace sold 161,021 shares of the stock in a transaction that occurred on Tuesday, August 4th. The stock was sold at an average price of $91.92, for a total transaction of $14,801,050.32. Following the sale, the chief executive officer owned 362,231 shares of the company's stock, valued at $33,296,273.52. This represents a 30.77% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Panagiotis Tsourapas sold 10,000 shares of the stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $92.05, for a total transaction of $920,500.00. Following the sale, the chief operating officer owned 64,901 shares in the company, valued at $5,974,137.05. This represents a 13.35% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 175,191 shares of company stock valued at $16,110,903. 0.43% of the stock is owned by company insiders.
Colgate-Palmolive Company Profile
(
Free Report)
Colgate-Palmolive Company NYSE: CL is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwashes, body washes, deodorants, soaps, household cleaning products and pet food and treats.
The company markets many of its products under well-known brands, including Colgate, Palmolive, elmex, meridol, Protex, Softsoap, Ajax, Irish Spring, Speed Stick, Tom's of Maine and Hill's Science Diet.
Read More
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.